First Manic Attack During COVID-19 Treatment: A Case Report
NALAN VARSAK *, MEHMET MERT TOPALOGLU , ELİF OZDEMİR
1Malazgirt State Hospital, 2Malazgirt State Hospital, 3Malazgirt State Hospital
Received: December 4, 2020; Revised: February 1, 2021; Accepted: February 2, 2021; Published online: February 2, 2021.
© The Korean College of Neuropsychopharmacology. All rights reserved.

Abstract
On March 11, 2020, the World Health Organization declared that the infection of novel coronavirus identified in Wuhan, China, is a pandemic. Various studies have shown that SARS-CoV-2 infection can trigger psychiatric effects such as anxiety, depression, and bipolar disorder. Here, we reported a case with no significant psychiatric history who experienced first-episode mania during the COVID-19 treatment. On the third day of hospitalization, the patient’s mood was elevated, she thought she can treat other patients with her special power, she was talkative and irritable. Olanzapine 20 mg was started and the patient’s score on the Young Mania Rating Scale decreased on the 17th day. Psychiatric outcomes associated with COVID- 19 are just emerging and it seems likely to be a potential engagement for psychiatric professionals in the future. More studies are required in terms of the treatment, course, and follow-up of psychiatric sequelae in these patients.
Keywords: COVID-19, mania, psychiatry


e-submission

Archives